A bstract
C le a r do c ume ntat io n of l ite r atu r e s e a r cli str ateg ie s a nd a n alysis met hodolog ie s
can im pr o v e tr a n s pa r e n cy in chem ical hazard a s s e ssme nts
W
e s o ug h t to i m pr o v ecla rit y fo r t he s cie nt if ic s up po rt fo r c a r cin oge nic me cha nism of a ct io n c o n clu sio n s u sing a
syste mat ic a p pr o a ch to c olle ct io n, s ele ct io n, pr e s e ntat io n, a nd e v alu at io n of lite r atu r e
stud ie s
W
e fo c u s ed on how d i(
2-et h y lhe xy l
)
p h t halate(
D E H P)
c a u s e s l ivertumo rige n esis, a quest io n c rit ic al to inte rpr et ing a la rge a nd c om p le x databa s e of >3
,0 0 0
pe e r-r e viewed
pub lic at io n s Rele v a nt me cha nisms of hepat ic c a r cin oge n e sis we r e
ide nt ifi ed fr om pub lished r e v iews T he lite r atu r e s e a r ch strateg y in cluded r ele v a nt
syn o ny ms a nd w ildcards fo r D E H P a nd metabolite s
, me cha nisms, a nd specie s of
interest T ie red evaluat ion c riteria fo r stud y e xclu sio n/ inclu sio n we r e def in ed
, a nd ap p lied
to t he r etriev ed lite r atu re Ma nu al c u r at ion was condu cted for me cha nisms w it h la rge
l ite r atu r e databa s e s L ite r atu r e tr e e s do c ume nted ide nt if ic at io n, c u r at io n a nd s elect io n of
t he lite r atu r e e vide n c e T he s e le cted stud ie s we r e s um ma riz ed in e vide n ce tab le s
a ccom pa nied b y s u c cin ct n a r r at iv e s Prima ry pub lic at io n s wer e made a v ailab le via t he
He alt h a nd En v iro nmental Re s e a r ch Onlin e
(
h t tp:/ / he r o epa go v/)
database , a ndide nt if ied b y e v alu at io n c rite ria a nd key te rms to pe rm it o rga niz ed r etrie v al. T h is
ap pro ach ef fe ct iv ely ma n age s a la rge v olume of literatu re, i m pr o v e s ap praisal and
synt hesis of info rmat io n, a nd e n ab le s a n alysis of sim i la rit y in me cha nism of act io n
Ackn o
w
led geme ntsSo ma ny pe op le ha v e hel ped me make t h is po s s ib le o v e r t he c o u r s e of t he pa st
ye a r t hat it is hard to kn ow w he re to start
F ir st a nd fo r emo st, I mu st t ha nk m y advis o r, Iv a n Ru syn, fo r tak ing a cha n c e o n a
j
aded e x-a c -adem ic po st do c w ho n e eded a c a r e e r cha nge I t h ink t h ings wo rked o ut
pr et t y well
I als o owe a deb t of gr at itude to m y mento r s at t he United S tate s En vironme ntal
Pr ote ct io n A ge n cy fo r mak in
g
m y O R I S E fel lowsh ip po s si b le—
e spe cial ly BobSo n awa n e, Kate Guy to n, a nd m y d ir e ct me nto r Andr ew Kr af t
—
^for al lof t heir sup po rt a nd
e n c o u r ageme nt a s t h is pr o
j
e ct matu r ed1co uld n ot ha v e a sked fo r a bet ter gr o up of c olleagu es to wo rk w it h o n t he D E H P
I R I S a s s e s s ment
—
chem ic al ma n age r Su e Makris, and te am mem be r s C hris Brinke rhof f,G ha zi Da n n a n , Yu -S he n
g L in , Rag hu Nat h, a nd Debo r ah Segal S pe cial t ha nks to
Co n nie S icke l
-Ka ng fo r he r ef fo rts a s wel l
T hanks to E lle n Lo rang, Ge r ry Gu e r e vich, a nd al l t he H E R O staf f, especially
Ra chel Ca r rie r e , R ya n Jo n e s, a nd Sa nd y P ham fo r t heir a s sista n ce .
A ls o t ha nks to Ja ck ie MacDo nald-G i bs o n fo r he r s u
p po rt a nd s e r vic e o n m y
t he sis c om m it te e A ls o t ha nks fo r t hat "H" in risk a s s e s sment but I gu e ss I e a r n ed t hat
o n e
To al l m y lab mates
(p
ast and pr e s e nt)
No u r A b do, Travis Bo ok, Gr ace C hap pel l,Su ng k yo o n K im , Ta nya Kobets, O ksan a Kosy k, Brid get O '
Brie n
, Andr ew S hap ir o ,
Svit la n a S h y mo nyak, Vale rie Soldatow , M yr o sla v S y pa, Je s s ic a
W
ign all, a nd Ho ng
-S ikYoo: T hanks for t he s up port, laug hs, gri pe s, a nd all t hat '
t he be st of luck and t hat we all e nd up w he r e we wa nt to be Rob in
—
s o gr e at to c atchup on c e again af te r so ma ny yea r s fu n ny how life brings peop le a r o u nd t he s ame way
again somet i mes
To Jae, t ha nl< yo u fo r yo u r u nw a vering s up po rt I hope Ha r v a rd is al l yo u wa nt it
to be . but
j
u st r emem be r U NC
w il l always ha v e t he leg up on pub l ic healt h, hehe ©So w he n yo u f ind me 'r o u nd "
Bahstahn" a nd "
Hahv ah d Yah d"
I got br ag g in' rig h ts o n t hat
o n e , '
k ?
To m y felin e c om pa nio n s of 1 1 5 ye a r s, Ta rget a nd Zo e , fo r t heir u n c o nd it io n al
lo ve and com pa nion sh i p, t hr o ug h t he be st of t i me s a nd, well, ot he r . Yo u t wo barf a lot
but t hat '
s ok
To m y mom a nd dad t ha nks fo r t he Be n
j
am in s©
! am s o fo rtu n ate to kn ow ITa b le of Co nte nts
C ha pter Pag e
L ist of Tab le s vi
L ist of F igu r e s vii
L ist of A b br e viat io n s vi ii
C
hap te r 1: intr odu ct io n 1C hap ter 2: Met hodolog y 9
C hap te r s: Re s ults 2 0
C hap te r4: D is c u s sio n 4 8
C hap te r 5: Pr a ct ic um Repo rt 5 6
L ist of Tab le s
Tab le Page
1: Ov e r all sea r ch str ateg y for D E H P, l iv e r, s elected mechanisms of a ct io n,
a nd spe cie s 1 2
2: Evaluat io n c rite ria u s ed in t he c o n side r at io n of in clu sio n a nd e x clusio n of
e vide n c e fo r D E H P me cha nisms of act io n in t h is c as e stud y 1 7
3: Ex am p le of a n e v ide n c e tab le fo r t he "pe r o xis ome pr ol ife r at io n"
mecha nism of a ct io n in rode nts 2 5
4 A: Ex a m p le of a n e vide n c e tab le fo r t he "pe roxisome prolife r ato r a ct iv ated r e c ep to r
"
(
P P A R)
me cha nism of a ct io n(
huma n s)
3 24 B: Eviden c e tab le fo r t he P P A R me cha nism of a ct io n in r ode nts 3 3
4
C
: Evi den c e tab le fo r t he P P A R me cha nism of a ct io n in pri mate s 3 55 A: Exam p le of a n e vide n c e tab le for t he "
gap
j
u n ct io n inte r c el lula rc om mu nicat io n"
(
G J IC)
me cha nism of a ct io n(
humans)
3 95 B; Evide n c e tab le fo r G J I C in r ode nts 4 0
5
C
: Evide n c e tab le fo r G J I C in n o n-hL ist of F igu r e s
F igu r e Page
1: T he 8-ste
p systemat ic fr amewo rk fo r l ite r atu r e re view for c o n s e n s us mecha nisms of a ct io n in t h is ca s e stud y fo c u sing o n D E H P
-indu c ed liv e r
to xicit y 1 0
2: Co n s e n s u s me cha nisms of a ct io n of D E H P in l iv e r a nd Pub Med s e a r c h
r esults fo r siz e s of lite r atu r e data ba s e s fo r e ach 2 2
3: L ite r atu r e tr e e fo r t he
"
pe r o xis ome pr ol ife r at io n
"
mecha nism of a ct io n 3 2
4: L ite r atu r e tr e e fo r t he
"
pe r o xis o me pr ol ife r ato r
-a ct iv ated r e c ep to r
"
mecha nism of a ct io n 3 8
5: L ite r atu r e tr e e fo r t he "G J i C"
L ist of A b br e v iat io n s
A h R
—
Ary l h y dr o c a rbo n r e c ep to rD E H P - D i
(
2-et h y lhe xy l
)p h t h
alateC A R
—
Co n st itut iv e a ndr o sta n e r e c ep to rE B T C
—
Evide n c e-Ba s ed To x ic olog y Col labo r at io n
G J I
C
- G ap
j
u n ct io n inte r c ellula r c om mu nic at io nG R A D E- Gr ad ing of Re c o m me ndat io ns, As s e ssme nt, De velop ment, a nd Ev alu at io n
H E R O
—
He a lt h a nd En vir o nmental Re s e a r ch Onlin eI R IS - Integr ated R isk Info rmat io n S ystem
M E H P- Mo n o-et h y l he x
y l p h t halate
Me S H
—
Med icals ubj
e ct he ad ingsM O A
—
Mode of a ct ionN R C
—
Nat io n al Re s e a r ch Co u n c ilN T P
—
Nat io nal To xic o log y Pr ogr a mP CoA
—
Palm itoy l-CoA OxidaC hap te r 1
Intr odu ct io n
Ov e r view T he r e view of la rge bod ie s of s cient if ic lite r atu r e du ring t he huma n
he alt h n sk a s s e s sme nt pr o c e s s r equir e s pr o c u r e me nt of qu alit y e vide nce in a way t hat is
tr a n s pa r e nt and r epr odu cib le , e s pe cial ly w it h r ega rd to t he pr oce s s of e x am ining a nd
pr e s e nt ing stud ie s key to u nde r sta nd ing a chem ic al '
s to xicit y. S yste mat ic guidel in e s fo r
t h is r e view pr o c e s s sho uld a ls o be ap p lic ab le to a s s e s s me nts o n bot h c a n c e r a nd
n o nc an c e r e nd points Howe ver, r ece nt r epo rts b y t he Nat io n al Re s e a rch Co u n c il
(
N R C)
h ig h l ig h t challen
g
e s a s s o ciated w it h t he c u r r e nt l ite ratu r e r e v iew and haz a rd a s s e s smentpr o c e s s e s
(
N RC
2 0 1 0, N R C 20
1 1)
. In pa rt ic ula r, e xist ing a s s e s sme nts do n ot s uf f icie nt lyde s c ri be t he ap pr o a c he s u s ed to se a r ch fo r a nd e v alu ate t he a v aila b le l ite r atu r e fo r a
g iv e n chem ic al, w h ich is e s s e nt ial to e n s u r e t he be st a v ailab le e vide n c e wa s in cluded in
t he a s s e s sme nt Im pr o ving t he r e v iew pr o c e s s to ad dr e s s t he c o n c e r n s pr e s e nted
abo v e w il l r e s ult in mo r e s cie nt if ic ally s o u nd a nd sta nda rd iz ed a s ses s me nts w it h a n
i m pact upo n r egulato ry de cisio n
-mak ing fo r huma n he alt h risks to e n vir o nme ntal
ha z a rds.
Syste
m
at ic Re views a nd Toxic olog y S ystemat ic r e view is t he prima ry to ol ofe vide n c e-ba s ed med icin e
, a clinic al init iat iv e in clud ing "
t he c o n s cie nt io u s, e xp licit, a nd
j
ud icio u s u s e of c u r r e nt be st e viden c e in mak ing de cisio n s abo ut t he c a r e of ind ividu alpat ie nts "
(
Sa cket t a nd Ro s e nbe rg 1 9 9 5)
T he r e view pr o c e s s is step w is e , fr am ing t hequ e st io n to be ad dr e s s ed, dete rm ining how stud ies w i ll be ide nt if ied a nd r etrie v ed,
dete rmining how studie s wi ll be in cluded o r e x cluded , ap pr aising in cluded studie s fo r
Exam p le s of systemat ic pr o c e s s e s t hat at tem p t to integr ate stud y r e s ults date
ba ck o ve r 2 5 0 ye a r s James L ind, a fellow of t he Royal College of P h ysicia n s in
E d inbu rg h, n oted t hat in t he tr eat me nt of s c u rvy, a "
full a nd im pa rt ialview "
of t he s ub
j
e ctwa s n e eded "
befo r e t he s ub
j
e ct c o uld be s et in a cle a r a nd pr ope r l ig h t "(
L ind 1 7 5 3)
T h is o bs e r v at io n led L ind to a ut ho r a do c ume nt w it h inquiry into t he n atu r e, c a u s e s, a nd
c u r es for t he d is e a s e In mo r e mode r n t i me s, bot h qu a nt itat iv e a nd qu alitat iv e met hods
ha v e bee n pr opo s ed to ad dres s v a riat io n s in prima ry r e s e a r c h, a nd pr ofe s sio n al
init iat iv e s ha v e de v eloped fr amewo rks a nd sta nda rds fo r c o ndu ct of syste mat ic r e views
Re ad ily-a v ailab le
guidelin e s of te n r efe r e n c ed a re pr o v ided b y t he Co chr a n e
Col labo r at io n, a n inte r n at io n a lnet wo rk of v olu nte e r s t hat pr epa r e r e views of r a ndom iz ed
c o ntr ol led trials fo r he alt h inte r v e nt io n s, t he Cam p be ll Co llabo r at io n, a n et wo rk of
pr ofe s s io na ls t hat pr epa r e r e views of t he ef fe cts of s o cial inte r v e nt io n s, a nd t he A ge n cy
fo r He a lt hca r e Re s e a r c h a nd
Q
u alit y a d ivisio n of t he U S Depa rt me nt of He alt h a ndHuma n Ser v ic e s t hat aims to demo n str ate how r e s e a rch r e s ults c a n be u sed to im pr o v e
he alt hc a re. S ta nda rds fo r systemat ic r e v iew a r e als o o ut lin ed in T he Ha nd bo ok of
Re s e a r ch S ynt he sis a nd Meta-An alysis
(
Co ope r et al 2 0 0 9
)
, a nd in Sum m ing U p: T heScie n c e of Re v iew ing Re s ear ch
(
L ig h t a nd P i lleme r, 1 9 8 4)
O f spe cial inte r e st toto xic o log ists, t he Evide n c e
-Bas ed To xic olo
g y Collabo r at io n ,
(
h t t p:/ /w w w eb to x c om)
a swel l a s t he Na v igat io n G uide Collabo r at io n
(h t t
p:/ /c oe.u c sf edu/prhe/n a viat ionquide str ateq v h t m l), e ngage s stakeholde r s fr o mv a rio u s profes sio n a l s e cto r s to pr odu c e gui da n c e do c ume nts w it h t he o ver a ll go al of
intr odu cing n o v el, f le xi b le ap pr o a che s to chem ic al ha z a rd a nd risk a s s essme nt t hat
in c o rpo r ate r e s e a r ch synt he se s a nd e vide n c e-ba s ed reviews
S yste mat ic r e view met hodolog ie s t hat e xp lo re t he r elat io n s h ip bet we en toxic s,
adv e r s e he alt h o utc ome s, a nd r egulato ry im pa cts c a n als o inf lu e n c e a nd info rm policy
of to xic olog ic al stud ie s be u s ed in pub lic he alt h de cisio n-m
a k ing r ega rd ing chem ic al
ha z a rds to e n s u r e t hat t he str o nge st s cie nt if ic e v ide n c e a v aila b le is c o n side r ed in t he
a s s e s sme nt of a n age nt of inte r e st In ad d itio n to t he s e r e c e nt r epo rts fr om t he N R C,
t he u s e of systemat ic r e view to u nde r sta nd a nd pr e s e nt e vide n c e fo r e n v ir o nme ntally
-indu c ed d is e a s e bu rde n is s ug gested in a r epo rt b y t he In st itute of Med icin e
(
2 0 0 8)
t hatde sc ribe s a c om prehen s iv e framewo rk fo r ev alu at in
g
he alt h ef fe cts res ult ing fr omchem ic a l e xpo su r e s in c u r r ed du ring m ilita ry s e r v ic e T he f ind ings fr om t h is r e view we r e
e xpe cted to guide de cisio n s r ega rd ing d is ab i lit y be n ef its r ewa rded to w a r v ete r a n s w it h
in
j
u rie s at tributab le to t he chem ic alsKey re co m me ndat io n s for res e a r ch synt he sis and r e view ha v e eme rged fr om
t he s e pr ofe s sio n al c ollabo r at io n s, advis o ry pa n els, ha nd bo oks, a nd ot he r r e c e nt r e v iew s
w it h gr e at con c o rda n c e bet we e n e nt it ie s An o v e r al l t he me to e me rge ha s be e n t he
e stab lish me nt of e vide n c e synt he sis stage s, w it h e v a lu at iv e qu e st io n s ad dr e s sing
spe cifi c a spects of stud ie s u nde r c o nside r at io n for in c lu s io n in t he review Su ch
qu e st io n s review w het he r o n e '
s s o u r c e s a nd s e a r ch str ateg ie s a r e e xp licit, if f irm
ed ito rial o r a s s e s sme nt c rite ria for stud y in clu s io n o r e x clu s io n a r e we ll-def in ed
, a nd if
si m ilar c od ing of stud y at tributes, s u c h a s a c c e p tab le s am p le siz e s or n um be r of
e xpe rime ntal trials, ha s be e n pe rfo rmed A c o m pr e hensiv e l ist of t we nt y qu e st io n s fo r
r e s ear ch synt he sis e v a lu at io n wa s pr opo s ed b y Ha r ris Co ope r
(
2 0 0 7)
, a nd in c lude sw het he r ap pr opriate s e a r ch te rms we r e ut i liz ed to m in e r ele v a nt lite r atu r e , if s ele ct io n
c rite ria we r e ap p lied c o n siste nt ly a nd r eliab ly a c r o s s stud ie s de e med f it fo r in clu sio n,
a nd if stud y de sign s we r e e xp licit ly def in ed U lt i mately, pr e s e ntat io n of r e s ults of t he
re s e arch synt he sis sho uld be clea r, w it h c om p lete do cume ntat ion of ap p l ied
met hodolog ie s in c luded Gr ap h ic al o r tabula r pr e s e ntat io n of e vi de nce f lows a nd
de cision-m
ak ing proc es s e s l ist ing c rite ria fo r ste p w ise choice s ar e n ew com po n e nts of
fr amewo rks fo u nd in t he pri ma ry lite r atu r e
(
Belgr ade et al 2 0 1 2,(
W
o odr uf f a nd Sut to n2 0 1 1
)
A key c o nside r at io n in e v alu at ing huma n he a lt h risks of chem ic als is t he huma n
r e le v a n c e of to x ic mode s of a ct io n obs e r v ed in a nimals Fr amewo rks to e v alu ate a nd
e xtr apolate mode s-of-a ct io n in e x
pe rime ntala ni mals ha v e be e n pr opo s ed fo r c a n c e r a nd
non-ca nc e r ef fe cts
(
So nich-Mullin et al 2 0 0 1; Bo ob is et a l 2 0 0 6; Bo o b is et al 2 0 0 8;
K la u nig et al 2 0 0 3
) (
Cohe n et al 2 0 0 3, 2 0 0 4; Me ek et al 2 0 0 3, Ba r s et a l 2 0 1 2)
Do u r s o n et al
(
2 0 0 8)
e x em p lifi e s t he ap pr o a ch in a s s e s sing t he e vide n c e fo r t wo mode sof a ct io n
(
he ritab le mutagenicit y and foll icula r c el l prolife r at ion)
fo r t h yroid tumo rigen e sisfr om a c ry lam ide S tud y r e s ults illu strat ing do s e-r e s
po n s e r elat io n sh ips fo r a c ry lam ide
e xpo s u r e a nd c e llula r damage e nd points we re e xpr e s sed in gr ap h ic al a nd tabula r
fo rmat, w it h a f in a l tab le l ist ing key e v e nts, r e lated e vide n c e , a nd p la u sib i lit y of e a ch
mode of a ct io n Brief, bulleted s um ma rie s fo r cha nge s in me a s u r ed e nd points a nd
co r re lat io n betwee n dos e- r e s
po ns e wer e in c o rpo r ated into t he o v e r all a s s essme nt
Howe v e r, a ma
j
o r we akn e s s of t he a n alysis wa s t hat t he a ut ho r s d id n ot pr o vide a nyinfo rmat io n o n s o u r c e s of s up po rt ing data fo r t he mode s of a ct io n stud ied
W
h ile t her epo rt w il l aid t he u nde r sta nd ing of w he r e t he chem ic al falls o n t he gr ad ie nt of huma n
e xpo s u r e and t he s e verit y of t he re s ult ing he alt h ef fe cts, t he fr amewo rk mu st fu rt her
d is c u ss str ateg ie s fo r m ining a nd s ele ct ing t he data u s ed in o rde r to ma x im iz e t heir
ef fe ct iven e s s in risk a s s e s sme nt O t he r l im itat io n s of t he mode of a ct io n framework
ap pr o a c h ha v e be e n ide nt if ied
(
Guy to n et al 2 0 0 8)
Ha z a rd Ide nt i fic at io n. L ite r atu r e Re vie w, a nd Human He al t h R isk As s ess
m
e ntCu r r e nt ly, a fo u r
-step a s s e s sme nt pa r ad ig m is u s ed to dete rm in e t he pote nt ial he alt h
risks of e n v ir o nme ntal che m ic al ha z a rds T he s e steps in clude 1
)
ha z a rd a s ses sme ntand ide nt ifi c at io n, 2
)
do se -respo n s e a s s e s sme nt, 3
)
e xpo s u r e asse ssme nt, a nd 4)
riskAs t he f ir st step in u nde r sta nd ing o v e r all risk, ha z a rd ide nt if ic at io n is c rit ic al fo r
t he integrit y of t he risk a s s e s sme nt pr o c e s s T he c u r r e nt r e v iew ap pr o a ch fo r ha z a rd
ide nt if ic at io n e m bod ie s eleme nts of c a u s al infe r e n c e of r elat ing e x po s u r e s to o utc ome s,
a nd eleme nts of Br ad fo rd H ill c rite ria t hat s e e k c o n siste n cy, str e ng t h, a nd spe cif icit y of
e v ide n c e
(
H ill 1 9 6 5)
A p pr o a che s pr e s e nt ing h ie r a r ch ie s fo r cla s sif y ing str e ng t h ofe v ide n c e a nd fo r r epo rt ing meta-a n alys e s a r e hall ma rks of do c ume nts t hat guide
pub lic
he alt h de cisio n
-mak ing
(
D H H S 2 0 0 4; S tr o up et al 2 0 0 0; lO M 2 0 0 8)
Toget he r, t he s emet hods w a r r a nt c o n s ide r at io n t hr o ug ho ut t he ha z a rd a s s e s sme nt pr o c e s s, w it h
pa rt ic ular em p ha sis upon e xp licit do c umentat io n of e viden c e s ele ct io n
Mode r n l ite r atu r e r e views to s up po rt ha z a rd a s s e s sme nt mu st c o n side r t he
s c ope a nd ma n age me nt of s e a r c h str ateg ie s a nd stud y in c lu sio n/e x clu sio n c rite ria
(
S m it h et al 2 0 1 1)
Se a r ch te rms sho uld be e xp l icit ly def in ed a nd r elated to spe cif icqu e st io n s ad dr e s s ed b y t he ha z a rd r e view, yet sho uld als o be br o ad e n o ug h in s c ope to
c a p tu r e al l r ele v a nt data Howe v e r, t he te rms sho uld be pr e cis e e n o ug h to a v oid
c a p tu r e of e xtr a n e o u s e vide n c e ir r ele v a nt to t he age nt of inte r e st Y ields of a rt icle s fr om
s e a r che s sho uld be d isp layed s u ch t hat do c ume ntat io n of how l ite r atu r e in cluded in t he
f in al r e view is m ined o n t he ba sis of e xp licit in clu sio n a nd e x c lu sio n c riteria T he N R C
(
2 0 1 1)
, in its r e v iew of E P A 's dr af t I R IS a s s e s sme nt of fo rmalde h y de , n oted t hat a list of
s e a r ch te rms u s ed r ele v a nt to t he che m ic al of inte r e st a nd its he alt h o utc ome s wa s n ot
pr o v ided In ad d it io n, t he IR I S dr af t la cked a de s c rip t io n of s e a r ch r e s ults ind ic at ing
n um be r s of a rt icle s in c luded o r e x cluded, a nd of in clu sio n/e x clu s io n c rite ria fo r stud ie s
O t he r d is c u s sio n s la ck ing in t he dr af t in clude adv a ntage s a nd lim itat io n s of stud ie s
ide nt if ied in t he s e a r ch a nd u s ed in t he a s s e s sme nt, a nd how t hey in c r e a s e o r de c r e a s e
wei g h t g iv e n to ep idem iolog ic al o r e xpe ri me ntal r e s ults in t he o v e r all ha z a rd e v alu at io n
(
U S E P A 2 0 0 5)
n a r r at iv e s de s c rib ing stud y r e s ults be r ep la c ed w it h e vide n c e tab le s t hat info rm a nd
s up po rt t he c o n c lu sio n s abo ut chem ic al ha z a rd a nd t he me cha nism of a ct io n, and t hat
stud y details, w hen ap pr opriate , may be p la ced into ap pe nd ice s T he us e of
sta nda rd iz ed tab le s fo r r epo rt ing sho uld cla rif y r e le v a n c e of t he e vide n c e to t he chem ic al
of inte r e st, its metabol ite s, me cha nisms of a ct io n, spe c ie s of inte r e st, o rig in a lit y of data,
do s e-c o n c e ntr at io n de sign
, r ep lic ate s a nd v a riab ilit y, a nd e xpe rime nta l detai ls a nd
r e s ults Follow ing t he tab le s, sho rt n a r r at iv e s um ma rie s fo r t he l in e s of e vide nce
p
r e s e nted sho uld e lim in ate t he n e ed fo r lo ng te xt de s c rip t io n s of stud ie s a s had be ensta nda rd in previo u s I R I S a s s e s s me nts Gr ap h ical to ols su ch a s decisio n tree s may
als o be em p loyed to aid vis u al iz at io n of e vide n c e c ap tu r e a nd s ele ct io n a nd
do c ume ntat io n of in clusio n a nd e x c lu sio n of lite r atu r e F in ally, t he lite r atu r e in cluded in
t he a s s e s sme nt sho uld als o be made a v ai la b le in a pub lic ally a c c e s sib le data ba s e s u c h
a s t he U S E P A
'
s He alt h a nd En vir o nme ntal Re s e a r ch Onlin e
(
H E R O,h t tp:/ / he r o epa g ov
)
databa s eD i (2-et hvl he xvl
)
Dh thalate as a c a s e study chem
ic al fo r a n ew e vi de n c e r e viewpr o c e s s
W
e cho s e a c a s e-stud y chem ic al w it h a la rge, c om p le x, a nd c o ntr o v e rsial
lite r atu r e databa s e fo r its propo s ed me cha nisms of a ct io n D i
(
2-et h y he xy l
)
p h t ha late(
D E H P)
, t he most c om mo n of t he cla s s of p h t halate p la st iciz e r s, was u s ed as a c a s estud y to de si gn a nd te st a fr amewo rk fo r ide nt if ic at ion of me cha nist ic e vide n c e r ele v a nt
to liv e r c a n c e r ha z a rd
D E H P is pr odu c ed fr om t he r e a ct io n of p h t halic a nh y dride w it h 2
-et h y lhe x a n ol
Oc c upat io n al a nd e n vir o nme ntal e x po s u r e s to huma n s a r e ub iquito u s, oc c u r ring t hr o ug h
u s e of p la st ic c o n s ume r pr odu cts a nd med ic al de vic e s , fo od intake, a nd air a nd s oi l
-related e xpo s u r e s
(W
it ta s s ek et al 2 0 0 7; Cola cin o et al 2 0 1 0)
D E H P is a chem ic alw it h a n e xte n siv e bod y of lite r atur e des cri b ing its me cha nisms of a ct io n in v a rio u s
ab i lit y to c a u s e c a n c e r
(
K la u nig et al 2 0 0 3; Guy to n et a l 2 0 0 8; Melnick et a l 1 9 87)
IVIu ch of t he e vide n c e fo r to xicit y of D E H P fo c u s e s upo n its pote nt ial a s a n e ndo c rin e
d is r up te r
(W
ils o n et al 2 0 0 8; Ge ntry et al 2 0 1 1)
, but it is als o a well-e stab lished r ode nt
liv e r c a r cin oge n
(
Melnick et al 1 9 8 7;Vo s s et al 2 0 0 5)
Huma n data o n t he c a r cin oge nicit y of D E H P a r e spa r s e a nd la rgely in c o n c lu siv e,
w it h po s sib le a sso ciat io n s infer r ed fr om ot he r chem ic als a ct ing t hr o ug h sim ila r mole c ula r
me cha nisms
(
Cum m ings a nd La s h 2 0 0 0; La sh et al 2 0 0 0;Ram d ha n et al 2 0 1 0)
T hu s ,D E H P may el icit c a r cin oge nic ef fe cts in huma n s Inde ed, s e v e r al huma n stud ie s ha v e
ad dr e ss ed pote nt ial hepatoto xicit y at tri butab le to D E H P a nd e xam ined t he r ole of
polyviny l ch lo ride
-c o ntaining med ic al de vic e s in D E H P e xpo s u r e s t hat may in c r e a s e risk
of hepatob la stoma
(
Reyn olds et al 2 0 0 4; Ma r uyama et al 1 9 9 9; Qu e et al 2 0 0 3)
Howe v e r, t he ma
j
o rit y of huma n e xpe ri me ntal data wa s o bs e r v ed in vi tr o in c ultu r edhuma n l iver c ells, w h ich may n ot r ep l ic ate r espo n s e s s e e n in viv o, a nd do n ot elicit
r e s po n s e s si m i la r to t ho s e obs e r v ed in c ultu r ed r ode nt c ells
Go als of t ti e pr oie ct
W
e s o ug h t to de v elo p a nd te st a mult i-step str ateg y t hat
wo uld ef fe ct iv e ly e v alu ate
, synt he siz e, a nd r epo rt s c ie nt if ic e vide n c e fo r a che m ic al w it h
a n e xte n siv e a nd c o ntr o v e r sial bod y of e vide n c e a v ailab le t hr o ug h pub licly s e a r cha b le
r e s o u r c e s
W
e de signed t h is met hodolog y to pr o v ide 1)
clear def init ion of t he qu e st io nof inte r e st's s c ope a nd c om pr ehe n s iv e , cle a r s e a r che s in pub lic databa s e s, 2
)
e xp l icitstateme nts of stud y a s s e s sme nt c rite ria in t he s ele ct io n of e v ide n c e , 3
)
vis u alr epr e s e ntat io n a nd s u c cin ct s um ma riz at io n of e vide n c e
, a nd 4
)
pub l ic a v ailab ilit y ofinfo rmat io n u s ed in t he a s s e s s me nt S pe cif ic ally
, we w ished to systemat ic ally r e view t he
liver c anc er ha z a rds of D E H P and pr e s e nt e videnc e to info rm its rele v a n c e in human s
T he c om po n e nts of t h is str ateg y in clude 1
)
cle a r spe cif ic at io n of a stud y qu e st io n; 2)
ide nt if ic at io n of r ele v a nt me cha nisms of a ct io n; 3
)
def init io n of a c om pr ehe n siv e s e a r chof e xp licit a s s e s sme nt c rite ria fo r stud y in clu sio n o r e x clu sio n; 5
)
s e a r ch a nde x am in at io n of t he Pub Med databa s e fo r lite r atu r e o n t he c o n s e n s u s me cha nisms of
a ct io n; 6
)
c o n str u ct io n of gr ap h ic al to ols do c ume nt ing t he s e a r c h a nd a s s e s sme ntpr o c e s s ; 7
)
pr e s e ntat io n of e vide n c e in s u c cin ct lite r atu r e tab le s a nd n a r r at iv es um ma rie s;a nd 8
)
o rga niz at io n of e vide n c e in a n o nl ine databa s e T h is str ateg y e n ab le sc om pr ehe n siv e , integr at iv e, a nd tr a n spa r e nt s e le ct ion a nd pr e s e ntat io n of e vide n c e
s up po rt ing t he c o n s e n s u s me cha nisms of a ct io n of D E H P U lt imate ly, t he go al of t h is
wo rk is to e xp lo r e op portu nit ie s to i m pr o v e clarit y and str e ng t h of t he scie nt if ic s up port
pr e s e nted in huma n he alt h risk a s s e s sme nts u s ed in r egulato ry de cisio n s fo r chem ic als
C ha p ter 2
Met hodolo g y
T he fr amewo rk fo r ide nt if ic at io n of e vide n c e to be in cluded o r e x cluded in t he
a s s e s sme nt of D E H P to xicity is il lu str ated in F igu r e 1 a s a f low cha rt
2.1
S
pe ci f ic at io n of t he stud y qu e st ion In S tep 1, a cle a rly spe cif ied stud yqu e st io n is ide nt if ied to info rm t he lite r atu r e s e a r ch str ateg y Fo r t h is c a s e stud y, t he
qu e st io n c o n c e r n s t he me cha nisms b y w h ich t he chem ic al
(
D E H P)
c a u s e s c a rcin ogenicha z a rd in t he ta rget t is s ue
(
liv e r)
T he signif ica n c e of t h is stud y qu e st io n fo r a s s e s s ingt he o v e r all haz a rd of D E H P is ba s ed o n mult ip le r epo rts of hepatoca r cin oge nic ha z a rd of
D E H P in t wo r ode nt spe cie s of bot h s e x e s upo n chronic e xpo s u r e
(
Melnick et al 1 9 8 7)
.A d d it ion ally, liv e r is amo ng t he mo r e s e n sit iv e ta rget o rga n s of c a r cin oge nicit y of D E H P
in r odents D if fe ring c o n clu s io n s ha v e be e n r e a ched abo ut t he pote nt ial r ele v a n c e of t he
liv e r tumo r fi nd ings in huma n s In c o ntr a st to t he 2 0 0 0 lA R C c o n clu sio n s r ega rd ing t he
ca r c inoge nic risks of D E H P
(
lA R C 2 0 0 0)
, t he 2 0 1 1 lA R CW
o rk ing Gro up e v a lu at ingD E H P c o n cluded t hat
"
t he huma n r ele v a n c e of t he mole c ula r ev e nts lead ing to D E H P
-indu c ed c a nce r in s e v e r a l ta rget t is s u e s
(
e g , liv e r and te st is)
in r ats o r m ic e co uld n otbe r uled o ut, r e s ult ing in t he e v alu at io n of D E H P a s a Gr o up 2 B agent, r at he r t han
Gr o up 3"
(
Gr o s s e et al 2 0 1 1)
Fo r t he s e r e a s o n s , t he que st io n of how D E H P c a u sesliv e r tumo r s may be info rmat ive fo r bot h qu al itat ive a nd qu a nt itat iv e c o n clu s io ns in
a s s e ssing its human he alt h ha zards As for D E H P, stud y
q
u e st ion s for ot he r chem ic alsw it h v olum in o u s lite r atu r e c o n cer ning c o ntr o v e r sial is s u e s r e le v a nt to he alt h ha z a rd
decision- mak in
g may be spe cif ied in t he c o u r s e of n o m in at io n o r e v alu at io n fo r
1
.Sp
e cif i
c ati
o n of
tl
i e stud y q
u e sti
o n2. I
d
e nt if
c a ti
o n of
th
e rel
evantm
e ch
a ni
sm
s of
actio n3. L
i
tera tu r e s e a r ch
stra
teg y
4. Esta
b l i
sh m
e nt of i
n cl
u si
o n/
e x cl
u si
o n c ri
te ri
a5
.Li
tera
tu r e s e a r ch
e s,m
e ch
a ni
sm
s of
a cti
o n6. Con str u ct
l
i tera
tu r e tr e e s, ea ch m
e ch
a ni
sm
7. Co n str u ct evi
d
e n c e tab le s a n
db
rief n a r r ativ e s um m a rie s8. Or
g
a ni
z e a nd
tag
e vi d
e n c eF ig u re 1. T he 8
-step systemat ic fr amewo rk
f
or lite ratu r e r e v iew fo r c o n s e n s u smechanisms of a ct ion in t h is c ase stud y focu sing on D E H P
-indu c ed liv e r to xicit y T h is is
a step w is e pr o c e s s fo r e vide n c e ide nt if ic at io n a nd a s s e s sme nt, beg in ning fr om s elect io n
of chem ical and ta rget t is s u e , to c o n str u ct io n of e vide n c e tab le s s um ma rizing lite r atu r e
ba s ed o n dete ct io n of t he chem ic al in t he huma n bod y, ind ic at io n s of huma n he alt h
r ele v a n c e, o r ind ic at io n s of e n vir o nme ntalc o ntam in at ion
(
N R C 1 9 9 1)
2 2 I de nt if ic atio n of r ele v a nt
m
e cha nisms of a c t io n Mo st e n vir o nme nta lchem ic als a r e t ho ug h t to be ope r at in
g
t hr o ug h mult i p le me chanisms a nd t he challe ngeof c om pr ehe n siv e r e v iew of t he c om p le xit ie s in t he me cha nism of a ct io n ha s be e n
r e v iewed
(
Geh l ha u s et al 2 0 1 1)
For t he pu rpo s e of t h is w o rk, we c o n str u cted anin clu siv e list of t he pote nt ial me cha nisms of D E H P-ind
u c ed liv e r c a r cin oge n e sis b y u sing
r ele v a nt r e views o n t he me cha nisms of liv e r ef fe cts of D E H P
(
K la u nig et al 2 0 0 3; Ru s yna nd Go rto n 2 0 1 2; Cald wel l 2 0 1 2; G uy to n et al 2 0 0 9; Robe rts et al 2 0 0 7; Ru syn et al
2 0 0 6; Pete r s et al 2 0 0 5
)
a ut ho r ed b y a d iv e r s e set of stal<e ho lde r s(
a c ade m ia,go v e r nme nt age n cie s, a nd t he indu stry
)
2 3 L i te r atu r e s e a r ch str ateg y A s e a r c h str ateg y was de vis ed to a c c o u nt fo r
me cha nist ic stud ies t hat may ha ve used bot h t he pa r e nt c om po u nd a nd /o r its
metabol ite s In t he ca s e of D E H P, many stud ies ha v e u s ed ma
j
o r metabolite s(
e g ,mo n o-et h y lhe x
y l p h t halate
)
to a c c o u nt fo r r ap id h y dr olysis of t he pa r e nt molec ule in t hega str o-inte st in al tr a ct T he init ial s e a r ch wa s c o ndu cted in P ub Med
( ht tp:/ / w w w n cb i nlm nih q o v/pub med /) u sing o nly
"
D E H P"
a s t he te rm, a nd t he n um be r
of r e s ults, a s well a s t he med ic al s ub
j
e ct he ad ing(
MeS H)
de c om po sit io n s , wer er eco rded a nd dated
(
Tab le 1)
To a cquir e me cha nist ic e vide n c e fo r metabol ite s ofD E H P, we c o n s ulted r e cent c om prehen s ive stud ies of D E H P metabolism in humans a nd
ot he r spe cie s
(
Lo rbe r et al 2 0 1 0; Lo rbe r et al 2 0 1 1; Sv e n s s o n et al 2 0 1 1; Teitelba umet al 2 0 1 2
)
to c r e ate a n in clu siv e string of r ele v a nt s e a r ch te rms T he e xpa nded s e a r chstring wa s s ub m it ted to Pub Med, again w it ho ut a ny lim its o r filte r s , a nd t he n um be r of
r e s ults a nd MeS H s ub he ad ings r e c o rded MeS H s ub he ad ings we r e v e rif ied fo r
r e lev anc e to t he s e a r ch te rms e nte r ed. If a ny s ub he ad ings de emed ir r e le v a nt
(
e g , n otTab le 1. Ov e r all s e a r c h str ateg y fo r D E H P, liv e r, s ele cted me cha nisms of a ct io n, a nd
spe cie s Se a r ch strings, Pub Med MeS H qu e ry tr a n slat ion s, a nd r etu r n ed r e s ults fo r
D E H P a nd its metabolite s, t he ta rget t issu e, s e le cted me c ha nisms of a ct io n, a nd spe cie s
of inte r e st Se a r che s pe rfo rmed Ju n e 2 5, 2 0 1 2
Le v elof Se a r ch Se a r ch S tring MeS H He ad ings
C hem ic al D E H P
(mo n o (3-c a rbo xy pr op y l)O R mcp p O R mo n o (2-e
t hy lhe xy l)
O R mo n o (2-e
t hy l-5-o x ohe x
y l) O R me oh p O R mo n o (2-e
th y l
-5-c a rbo x
y pe nty l)O R me cp p O R mo n o (2-e
t h y l-5
-hy dr o xy he xy l) O R meh p O R
de hp O R 2-et hy lh
e x a n ol O R
(p ht halic a cid)O R (2-et h y l-5
-hy dr o xy he xy l) O R M E H H P O R
(2
-carboxy met h y l)O R M E C P P O R M M H P O R (2-eth y l-5
-o xy he xy l) )
"
d iet hy lhexy l p h t halate"[MeS H Te rms]O R ("
d iet hy lhe xy l"[A II F ie lds]A N D "p h thalate"[A II
F ields]) O R"d iet h y lhe xy l p ht halate"[A II F ields]
O R "
deh p"[A II F ields]
mo n o[A II F ields]A N D 3-c a rbo x
y pr op y l[A II F ields]O R mcp p[A II F ields]O R mo n o[A II F ields]A N D 2-e
t h y lhe xy l[A II F ields]O R mo n o[A II F ields]A N D 2-e
t hy l-5-o x ohe x
y l[A II F ields]O R ("
met hy lp ho sp h ite"[Sup pleme nta ry
Co n c ep t]O R"
met hy lp ho sp hite
"
[A II F ields]O R
"
me op h"
[A II F ields]) O R mo n o[A II F ie lds]A N D 2-et hy l-5-c a rbo x
y pe nty l[A II F ie lds]O R ("2
-meth y l-5 ,6
-cyclope ntap yrim id in e"[Sup p leme nta ry
Co n c ept]O R"2-met hy l-5 ,6
-cyclope ntap yrim id in e"[A II F ie lds]O R
"
me cp p"[A II F ie lds] )O R mo n o
[A II F i
elds]A N D 2-et hy l-5-h y dr o xy he xy l[A II F ie lds]O R ("mo n o
-(2-e
t hy lhe xy l)p ht halate
"
[Supp leme nta ry Co n c ept]O R"mo n o
-(2
-et h y lhe xy l)p ht halate"[A II F ie lds] OR
"
meh p"[A II F ields]) O R("d iet h y lhe xy l
p ht halate "[MeS H Te rms]O R ("
d iethy lhe xy l"[A II F ields]A N D "p hthalate"[A II
F ields]) O R"d iet h y lhe xy l p ht halate"[A II F ields]
O R "
deh p"[A II F ields] )O R ("2
-et h y lhe x a n or
'
[Supp leme nta ry Co n c ept]O R
"
2-et hy lhe x a n ol "
[A II F ields]O R
"
2
et h y lhe x a n or
'
[A II F ields]) O R(
"
p ht halic a cid
"
[Sup p leme ntary Co n c ep t]O R "
p ht halic a cid"[A II F ields] )O R 2-et hy l-5
-h y dr o xy he xy l[A II F ields]O R("mo n o-(2
-et h y lhe xy l)p h thalate
"
[Sup p leme nta ry Co n c ept]O R"
mo n o
-(2
-et h y lhe xy l)p hthalate"
[A II F ie lds]O R
"
meh p
"
[A II F ields] )O R 2-c a rbo x
ymet h y l[A II F ields]O R C'
2-me
t hy l-5 ,6
-cyclope ntap yrim id in e"[Sup p le me nta ry
Co n c ep t]O R"
2-me
t hy l-5 ,6
-cyclope ntap yrim id in e"[A II F ie lds]O R
"
me cp p"[A II F ields]) O R ("
mo no-5
-met hy lhe xy lp ht halate"[Sup p leme nta ry Co n c ep t]O R "
mo n o-5
-met hy lhe xy lp hthalate"[A II F ields]O R
"
m m h p"
[A II F ields]) O R (2[A II F ie lds
]
A N Dethy l[A II F ields]A N D 5[A II F ields]A N D
o xy he xy l[A II F ields] )
T is s u e liv e r
(liv e r O R hepato*
)
liv e r[MeS H Te rms]O R "
liv e r"[A II F ields]
("
liv e r"[MeS H Te rms] O R "
liv e r"[A II F ields])
O R (hepato[A II F ields]O RH )
%
W
ildc a rd s e a r ch for'hepato*'
r e sults in mo r e t ha n 60 0v a riat io n s, he n c e t he s e a r ch u s e s only t he fir st
Tab le 1
(
c o nt in u ed)
Le v el of Se a r ch Sea rch S t ri ng MeS H He ad in gs
Me cha nism (pe r o xis ome pr olife r atio n)
(per o xis* )
("
pe r o xis ome s"[Me S H Te rms]O R "
pe r o xisome s"[A II F ields]O R"
pe r o xis ome"[A II F ields])A N D prolifer atio n[A II F ields]
pe r o xis[A II F ields]O R pe r o xisc a n[A II F ie lds]
O R pe r o xlside s[A II F ields]O R pe roxismal[A II F ie lds]O R pe r o xisme[A II F ields]O R
pe r o xisme s[A II F ie lds]O R pe r o xismo s e[A II F ields]O R pe r o xis om[AI I F ields]O R
pe r o xis oma[A II F ields]O R pe r o xis omal[A I I
F ields
]
O R pe r o xis omal/ g lo xys omal[
A II F ields]
O R pe r o xis omal/ g lyoxysomal[A II F ields
]
O R pe roxis omal/ m ito chondrial[
A II F ields]
O R pe r o xis omal/ m yelin[A II F ields]
O R pe r o xis omal/n u cle a rlA II F ields]O Rpe r o xis omalbeta[A II F ields
]
O R pe r o xis omale[A II F ields]O Rpe r o xis omale n[A II F ields]O R
pe r o xis omale s[A II F ields]O R
pe r o xisomally[A II F ields]O R pe r o xis omalni
(
A IIF ie lds]O R pe r o xis omalniho[A II F ields]O R
pe r o xis omas[A II F ields]O R pe r o xis om brist
(
A IIF ie lds]O R pe r o xisome[A II F ields]O R
pe r o xis ome/ m ito cho ndria
[
A II F ields]
O Rperoxls ome/v a c uole[A II F ields
]
O R per o xis ome'[
A II F ields]
O R pe r o xis ome' s
[
A IIF ields]O R per o xis omed b[A II F ields]O R
peroxis omed ivisio n
[
A II F ie lds]O Rperoxis omelike[A II F ields] O R pe r o xis ome n[A II
F ie lds]O R pe r o xls ome ndefekt[A II F ields]O R
per o xis omeninduk t ion[A II F ields
]
O Rper o xis omenpr olife ratio n[A II F ields]O R
per o xis omenpr olife rato rfA II F ields]O R
per o xis omepr ollfe r ato r s[A II F ields]O R
per o xis ome r s[A II F ields]O R pe r o xis ome s[A II
F ie lds]O R pe r o xis ome s/c ell[A II F ields]O R
per o xis ome s/chem istry[A II F ields]O R
per o xis ome s/clas sif lc at io n[A II F ields
]
O Rper o xis ome s/cm 3[A II F ie lds]O R per o xls omes/enzy molog y[A II F ields
]
O R per o xis omes/ ge n etlcs[A II F ields]
O Rper o xis ome s/g lyo xysomes[A I I F ields
]
O Rper o xis ome s/ im mu n olog y[A II F ie lds] O R
per o xis ome s/ metabolism[A II F ields]O R
pe r o xis ome s/ m ic r obiolog y
[
A II F ields]
O Rperoxis omes/ m ito chondria
[
A II F ields]
O Rpe r o xisomes/para sito log y[A II F ields
]
O R per o xis ome s/ pat holog y[A II F ields]O Rper o xisome s/ p hysiolog y
[
A II F ie lds]O R per o xisomes/s e c retion[
A II F ields]
O Rpe r o xls ome s/ultr a s o n ogr ap h y[A II F ields]O R
pe r o xisome s/ultra str u ctu r e[A II F ields]O R pe r o xis ome s/vlr olog y
[
A II F ields]
O R peroxls ome s'[
A II F ields]
O R peroxis om ial[
A IIF ields]O R per o xis om ic[A II F ields]O R per o xis om icin e
[
A II F ie lds]
O R pe r o xis om icine s[A II F ields]O RTab le 1
(
c o ntin u ed)Le v elof Se a r ch Se a r ch S trin g MeS H He ad in g s
Me cha nism (c o ntin u ed)
(pe r o xis
*
) (c o ntin u ed)
(c ell pr olife r at io n)
((c ell pr olife r atio n)O R (c ell gr ow t h)O R (dn a r ep lic atio n) O R (dn a synt he sis)O R (r ep lic at iv e dn a synt he sis)O R m ito sis O R (cell d ivisio n)O R (gr ow t h r e spo n s e) O R h y pe rpla sia O R hepatomegaly)
(
o xidat iv e str e s s)(o xidat iv e stre s s O R o xidat iv e O R(r e a ctiv e o xy ge n)O R(lip id pe r o xidatio n)O R r edu c ed g lutat h io n e O R (g lutath io n e
pe r o xidas e)O R c atala s e O R (o xidat iv e D NA damage)O R hy dr o xy gu a n o sin e)
pe r o xis omopath ie s[A II F ie lds]O R pe r o xis omopat h y[A II F ie lds]O R pe r o xis omotr op ic
J
A II F ie lds]O Rpe r o xis omu[A II F ields]O R pe r o xis o n e[A II F ields]O R pe r o xis o ne s[A II F ields]O R pe r o xis o om[A II F ields]O R pe r o xis s oma[A II F ields]
c e ll pr olife r atio n[MeS H Te rms] O R ("c ell"[A II F ie lds] A N D "pr olife r at io n"[A II F ields]) O R
"
c ell pr olife r atio n"[A II F ields]
("c ell pr olife r at io n"[l\/leS H Te rms]O R ("c ell
"
[A II F ields]A N D
"
pr olife r at io n
"
[A II F ields] )O R
"
c ell pr olife r at io n
"
[A II F ields]) O R (("c ells
"
[MeS H Te rms]O R
"
c e lls
"
[A II F ields] O R"
c ell
"
[
A II F ields] )A N D ("
gr ow t ha nd dev elopme nt
"
[
Sub he ad ing]O R ("
gro wt h"
[A II F ields
]
A N D"
develop me nt
"
[A II F ields] )O R
"
gro wt h a nd de v elopm ent
"
[A II F ields
]
O R"
gr owt h"
[A II F ields]O R
"
gr ow t h
"
[MeS H
Te rms]))O R (
"
dn a r ep lic atio n
"
[MeS H
Te rms]O R(
"
dn a
"
[A II F ields]A N D "
r ep lic at io n
"
[A II F ields] )O R
"
dn a r ep lic at io n
"
[A II F ields] )O R (
"
dn a r ep lic at io n
"
[MeS H Te rms]O R (
"
dn a
"
[A II F ields]A N D
"
r ep lic at io n
"
[A II F ields] )O R
"
dn a r epl ic atio n
"
[A IIF ields]O R (
"
dn a
"
[A II F ields]A N D
"
synt he sis
"
[A II F ields])O R
"
dn a synt he sis
"
[A II F ields])O R (r ep lic at iv e[A II F ields]A N D (
"
dn a r ep lic at ion
"
[Me S H Te rms] O R
(
"dn a
"
[
A II F ie lds]
A N D"
r ep lic at ion
"
[
A II F ields] )O R "dn a r ep lic at io n
"
[A II F ields]O R ("dn a
"
[A II F ields]A N D
"
synt he sis
"
[A II F ields] )O R
"
dn a synt he sis
"
[AI IF ields] ))O R ("
m ito sis
"
[MeS H Te rms]O R
"
mito sis
"
[A II F ields] )O R ("c ell d ivisio n
"
[MeS H Te rms]O R ("
c eir'[A II F ields]A N D
"
d ivisio n"[A II F ields]) O R"
c ell d ivisio n
"
[A II F ie lds
]
)O R (("
gr ow t h a nd de v elopme nt"[Subhe ad ing]O R ("
gr ow t h"[A II F ields]A N D
"
de v elop me nt"
[A II F ields] )O R "gr ow t ha nd de v elop ment"[A II F ields]O R"gr ow t h"[A II F ields]O R
"
gr ow th"
[MeS H Te rms])A N D r e spo n s e[A II F ields] )O R ("h y pe rp la sia"[MeS H Te rms]O R
"
h y pe rp lasia"
[
A II F ields]
) O R("
hepatomegaly"[MeS H Te rms]O R
"
hepatom egaly"
[A II F ields]
)
o xidativ e str e s s[Me S H Te rms]O R ("
o xidativ e"
[
A II F ields]A N D "str e s s"[
A II F ields] )O R "o xidat iv e str e s s"[
A II F ields]("
o xidat iv e str e s s"[MeS H Te rms]O R ("
o xidat iv e"[A II F ields
]
A N D "str e s s"[A II F ields] )O R "o xidat iv e str e s s"[A II F ields]) O R o xidativ e[A II F ields]O R (r eactiv e[A II F ields] A N D ("o xy ge n"
[MeS H Te rms]O R
"
"
SST" "
**"""?
Ta b le 1
(
c o nt in u ed)
Le v elof Se a r ch Se a r ch S tring MeS H He ad ings
Me cha nism
(c o ntin u ed)
(oxidativ e str e s s O R o xidat iv e O R (r e a ct iv e o xy ge n) O R (lip id pe roxidat io n) O R r edu c ed g lutat hio n e O R (g lutat h io n e pe r o xida s e) O R c atala s e O R
(o xidativ e D NA damage) O R
h y dr o xy gu a n o slne) (c o ntin u ed)
pe r o xidatio n"[Me S H Te rms]O R ("lip ld"[A II F ields]A N D "
pe r o xidatio n"
[A II F ields] )O R "
lip id pe r o xldat io n"[A II F ie lds])O R
("
g lutath io n e"
[MeS H Te rms]O R "
g lutat h lo n e"[A II F ields]O R ("r edu c ed"[A II F ields]A N D "
g lutathlo n e"
[A II F ields]) O R "
r edu c ed g lutat h lo n e"[A II F ields]) O R
("
g lutat h io n e pe r o xida se
"
[MeS H Te rms] O R
("
g lutat h io n e"
[A II F ields]A N D "
pe r o xlda s e"[A II F ields]) O R"
g lutath io n e pe r o xida s e"[A II F ields])O R
("
c atala s e"
[Me S H Te rms]O R"
c atala s e" [A II F ields]) O R (o xldat iv e[A II F ields]A N D ("
dn a damage"[MeS H Te rms]O R ("
dn a"[A II F ields] A N D "
damage"[A II F ields]) O R" dn a damage"
[A II F ields] ))O R hydr o xy gu a n o sin e[AI IFields]
S pe cie s (huma n)
(human O R homo s ap ie n s)
(mo u s e o r r at)
(mo u s e O R r at O R hamster O R
r ode nt O R mu rin e O R Mu s
mu s c ulu s o r Rat tu s)
(primate)
(primate o r mo nkey)
huma n s[MeS H Te rms]O R "
huma n s"[A II F ields]O R"
huma n"[A II F ie lds]
("
huma n s"[Me S H Te rms]O R "
huma n s"[A II F ields
]
O R"huma n "
[A II F ields]) O R
(" huma n s
"
[Me S H Te rms]O R "
huma n s"[A II F ields]O R("
homo"[A II F ields
]
A N D "s ap ie n s"[A II F ields
]
)O R "homo s ap ie n s"[A II F ields])
(" m lc e"
[MeS H Te rms]O R" m ic e"
[A II F ields] O R "
mo u s e "
[A II F ields] )O R r at[A II F ields]
(" m ic e"
[MeS H Te rms]O R" m ic e"
[A II F ields] O R "
mo u s e "
[A II F ields] )O R r at[A II F ields] O R ("
c ric etln a e"
[MeS H Te rms]O R "
c rlc et in a e"[A II F ields]O R"hamste r"[A II F ields] )O R ("r ode ntla"
[MeS H Te rms]O R "
r ode nt ia"[A II F ields]O R"r ode nt"[A II F ields]) O R ("
m ic e"
[MeS H Te rms]O R "mice"
[
A II F ields]
O R"mu rln e"[A II F ields]) O R("
mic e"
[
MeS H Te rms]O R" m lc e"[A II F ields] O R ("
mu s"[A II F ie lds]A N D "mu s c ulu s"
[
A II F ields]) O R "mu s mu s c ulu s "
[A II F ie lds] )O R
("
r ats"[IVIeS H Te rms]O R"r ats"[A II F ie lds] O R"
r at tu s"[A II F ields])
primate s[MeS H Te rms]O R"primate s"[A II F ields]O R"
pri mate"[A II F ields]
("
primate s"[MeS H Te rms]O R "primate s"[A II F ields]O R
"
prlmate"[A II F ields] )O R
("
haplo rh ini"[MeS H Te rms]O R "
hap lo rh ini "
tr a n slat io n, a nd t he s e a r ch wa s re pe ated w it h a ny cha nge s in r esults r eco rded
2.4 Estab lish
m
e nt of in clu sio n/e x clu sio n c ri te ria Tab le 2 l ists t ie r ed c rite ria b yw h ich r etrie v ed lite r atu r e wa s s c r e e n ed fo r inclu sio n into e vide n c e ta b le s fo r e a ch
c o n s e n s u s me cha nism of a ct io n T he T ie r 1 c rite ria u s ed in ev alu at ing all of t he r etrie v ed
lite r atu r e databa s e s c o n side r ed w het he r t he pub lic at io n ad dr e s s ed t he chem ic al, t is s u e,
me cha nism, a nd spe cie s of inte r e st, a nd c o ntain ed o rig in al data If a pa rt ic ula r
me cha nism of a ct io n ha s be e n a s ub
j
e ct of ma ny stud ie s(
e g , t he n um be r of r e le v a ntpub lic at ions e xc e ed ing 2 0
)
, T ier 2 crite ria we r e ap p l ied to ad dr e ss stud y 's cla rit y,
com p lete ness, a nd s ou ndne s s For exam p le , gre ate r weig h t wa s as sign ed to stud ie s
t hat em p loyed do s e-r e s
po n s e de sign s
, in cluded a la rge n um be r of r ep l ic ate s, r epo rted
e xperi me ntal v a riab il ity
, and provided cle a r desc rip t io n of t he met hodolog y T he s e
in clu sio n a nd e x clu sio n c rite ria we r e info rmed b y t he E P A
'
s s um ma ry of ge n e r al
a s s essme nt fa cto r s o n e v alu at io n of scie nt if ic a nd te chnic al info rmat io n
(
E P A 2 0 0 3)
a ndU S E P A'
s Guidelin e s fo r Ca r cin oge n R isk As s e s s
m
e nt(
E P A 2 0 0 5)
2 5 L i teratu r e s e a r che s,
m
e chanisms of a ctio n T he s e a r ch string fo r D E H P a ndits metabolite s wa s e xpa nded to in c o rpo r ate t he ta rget t is s u e
(
liv e r)
, t he me cha nism, a ndt he re le v a nt spe cie s of inte r e st to build a lite r atu r e databa se of e vide n c e Ba s ed o n t he
c om pr ehe n s iv e r e v iews
(
s e e s e ct io n 2 2)
, we s ele cted t hr e e t y pe s of spe cie s, huma n s,n o n-h
uma n primate s, a nd r ode nts
(
r at o r mo u s e)
, a s mo st r elev a nt fo r t he pu rpo s e ofc o n stru ct ing t he e vide n c e ta b le s fo r D E H P a s a case stud y To auto mate t hes e s ear ches
to t he gr e ate st e xte nt po s si b le , we dete rm in ed t hat t he u s e of w il dc a rds a nd synony ms
fo r r ele v a nt s e arch te rms w a s mo st ef fe ct iv e in ide nt if y ing r e le v a nt lite r atu r e
(
Ta b le 1)
As des c ribed in s e ct io n 2.3, Pub Med res ults we re r e c o rded and dated, in clud ing MeS H
s ub he ad ings fr om t he qu e ry
2 6 Co n str u ct io n of the li te r atu r e tr e e s, in t he n e xt step, lite r atu r e tr e e s we r e
Ta b le 2 Ev alu at io n c rite ria u s ed in t he c o n side r at io n of in clu s io n a nd e x clu sio n of
e vide n c e fo r D E H P me cha nisms of a ct io n in t h is c a s e stud y
T ie r s In clu sio n/ Ex clu sio n Crite ria
T ie r 1:
A p p lic ab ility a nd U t ilit y
(
A p p lied to all s e a r che s)
1 D id t he stud y e v alu ate ef fe cts of t he chem ic alof inte r e st o r its metabolite s kn own to be fo rmed in huma n s?
2 D id the stud y e v alu ate ef fe c ts in t he tis s u e
(
o rga n)
of inte r e sto r c ells de riv ed fr om t h is t is s u e?
S D id t he stud y e v alu ate c el lula r, b io chem ic al o r mole c ula r
ef fe cts r ele v a nt to t he me cha nism u nde r c o n side r atio n?
4 D id t he stud y in clude info rmat io n s uf f icie nt to dete rm in e w hat
spe cie s we r e stud ied ?
S Do e s the pub lic at io n in c lude o rig in al data?
T ie r 2:
C la rit y,c om p lete n e s s,
s o u ndn e s s
(
A p p lied tome cha nisms w it h large databa s e s
)
e D id t he stud y em p loy do s e-/c o n c e ntr at ion
-r e spo n s e de sign?
T Do e s t he stud y c o ntain s uf f icie nt n um ber of r ep lic ate s w it h in
e a c h e xpe rime ntal gr o up to e v alu ate signif ic a n c e of t he ef fe ct ?
8 Do e s t he stud y r epo rt v a riab ilit y w it h in e a ch e xpe rime ntal
gr o up /c o nd it io n?
c o n side r ed fo r in clu sio n into t ii e e vide n c e tab le s Beg in ning fr om t he h ig he st le v e lof t he
tr e e, t he chem ic a l of inte r e st, pub licat io n s t hat we r e n ot r e le v a nt to t he ta rget t is s u e,
s e le cted me cha nism, o r spe cie s we r e r emo v ed A f te r e x clud ing r e views, a s dete rm ined
b y Pub Med, full te xt r efe r e n c e s we r e t he n r etrie v ed fo r ma n u ale v alu at io n a nd in clu s io n
into e vide n c e tab le s, w it h T ie r 2 a s s e s sme nt c rite ria ap p lied to la rge databa s e s T he
ma n u al c u r at io n of t he a rt icle s ide nt if ied mo st r e le v a nt pub lic at io n s t hat met all of t he